Caribou Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Caribou Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Caribou Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.07M, a 17% increase year-over-year.
  • Caribou Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $16.4M, a 23% increase year-over-year.
  • Caribou Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.8M, a 17.4% increase from 2022.
  • Caribou Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.7M, a 240% increase from 2021.
  • Caribou Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.45M, a 244% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.8M +$2.03M +17.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $11.7M +$8.27M +240% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 $3.45M +$2.45M +244% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $1M -$232K -18.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 $1.23M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.